OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Optimizing these processes involves modifying various factors, including cell line development, media composition, and bioreactor settings. A key goal is to amplify antibody production while reducing production financ